Rubric Capital Management (New York)’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
Rubric Capital Management (New York)'s SBBP Position: Q4 2021 in Review
Rubric Capital Management (New York) sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 3,072,732 shares — an estimated $6.27M sold.
Rubric Capital Management (New York) first reported a position in SBBP in Q2 2021 and held it in 2 quarters. The position peaked at $8.01M in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- Rubric Capital Management (New York) reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- Rubric Capital Management (New York) sold 3,072,732 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $6.27M.
- Rubric Capital Management (New York) first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 2 quarters.
- Rubric Capital Management (New York)'s Strongbridge Biopharma plc. position peaked at $8.01M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on Rubric Capital Management (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.